EVAKSINE AS

Signals

2 flags

• ▼ Negativ egenkapital 2024 Bokført egenkapital er negativ (−1,0 mill kr).
• ▼ Driftsunderskudd 2024 Siste driftsresultat er negativt (−577k kr).

EVAKSINE AS is registered as a limited company in Oslo, Oslo with organisation number 921746318. The business is classified under other health services (NACE 86.993). The company was incorporated in 2018. Registered share capital is NOK 30,000, divided into 30000 shares. The company's stated purpose is: “Legevirksomhet, virksomhet innen helse, e-helse, IKT, rekruttering, konsulentvirksomhet, medvirkning i andre selskaper, kjøp, salg og forvaltning av aksjer og andeler i andre selskaper, samt alt som hører naturlig til dette.”. The most recent filed accounts, for the 2024 financial year, show NOK 5.6m in revenue and NOK −577,000 in operating profit.

Key figures · 2024

Revenue

NOK 5.6m

Operating profit

NOK −577,000

Equity

NOK −1.0m

Financial health · 2024

Liquidity

0.37

Not satisfactory

Current assets ÷ current liabilities

Profitability

–

Not available

Return on total assets

Solidity

-287.2%

Weak

Equity as a share of total capital

Solidity capped at Weak because equity is below NOK 100,000.

Who owns EVAKSINE AS?

UPNORTH INVEST AS

47.5%

EVAKSINE AS

NOK 5.6m rev. · NOK −577,000 profit

EVAKSINE AS has 4 registered shareholders:

• UPNORTH INVEST AS 47.5%
• ISTRE HOLDING AS 25.7%
• DE BRUYCKER HOLDING AS 21.9%
• BJERKHOLDT HOLDING AS 5.0%

All shareholders and roles →

Frequently asked questions about EVAKSINE AS

Who owns EVAKSINE AS?

UPNORTH INVEST AS is the largest registered owner, with 47.5%.

What is the revenue of EVAKSINE AS?

EVAKSINE AS had revenue of NOK 5.6m in 2024.

Where is EVAKSINE AS based?

EVAKSINE AS has its business address in Oslo.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.